<code id='182DA5E336'></code><style id='182DA5E336'></style>
    • <acronym id='182DA5E336'></acronym>
      <center id='182DA5E336'><center id='182DA5E336'><tfoot id='182DA5E336'></tfoot></center><abbr id='182DA5E336'><dir id='182DA5E336'><tfoot id='182DA5E336'></tfoot><noframes id='182DA5E336'>

    • <optgroup id='182DA5E336'><strike id='182DA5E336'><sup id='182DA5E336'></sup></strike><code id='182DA5E336'></code></optgroup>
        1. <b id='182DA5E336'><label id='182DA5E336'><select id='182DA5E336'><dt id='182DA5E336'><span id='182DA5E336'></span></dt></select></label></b><u id='182DA5E336'></u>
          <i id='182DA5E336'><strike id='182DA5E336'><tt id='182DA5E336'><pre id='182DA5E336'></pre></tt></strike></i>

          entertainment

          entertainment

          author:entertainment    Page View:4
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Keeping primary care docs in field isn't impossible, says AAFP CEO
          Keeping primary care docs in field isn't impossible, says AAFP CEO

          R.ShawnMartin,theCEOoftheAmericanAcademyofFamilyPhysiciansCourtesyAmericanAcademyofFamilyPhysiciansI

          read more
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more

          What STAT readers think about the FDA and patient advocacy

          MollyFergusonforSTATSTATnowpublishesselectedLetterstotheEditorreceivedinresponsetoFirstOpinionessays